Larry M. Baddour

95.4k total citations · 11 hit papers
456 papers, 25.1k citations indexed

About

Larry M. Baddour is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Larry M. Baddour has authored 456 papers receiving a total of 25.1k indexed citations (citations by other indexed papers that have themselves been cited), including 312 papers in Epidemiology, 207 papers in Infectious Diseases and 120 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Larry M. Baddour's work include Infective Endocarditis Diagnosis and Management (226 papers), Antimicrobial Resistance in Staphylococcus (129 papers) and Streptococcal Infections and Treatments (108 papers). Larry M. Baddour is often cited by papers focused on Infective Endocarditis Diagnosis and Management (226 papers), Antimicrobial Resistance in Staphylococcus (129 papers) and Streptococcal Infections and Treatments (108 papers). Larry M. Baddour collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Larry M. Baddour's co-authors include James M. Steckelberg, Kathryn A. Taubert, Walter R. Wilson, Michael H. Gewitz, Ann F. Bolger, Matthew E. Levison, Walter R. Wilson, Peter B. Lockhart, Imad M. Tleyjeh and Gordon D. Christensen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Larry M. Baddour

431 papers receiving 24.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

2015 1.9k citations Larry M. Baddour, Walter R. Wilson et al. Circulation profile →
Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices

1985 1.8k citations Larry M. Baddour et al. profile →
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease

2004 1.4k citations Walter R. Wilson, Larry M. Baddour et al. Circulation profile →
Infective Endocarditis

2005 1.2k citations Larry M. Baddour et al. Circulation profile →
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association

2004 990 citations Walter R. Wilson, Larry M. Baddour et al. profile →
Periodontal Disease and Atherosclerotic Vascular Disease: Does the Evidence Support an Independent Association?

2012 770 citations Walter R. Wilson, Larry M. Baddour et al. Circulation profile →
Update on Cardiovascular Implantable Electronic Device Infections and Their Management

2010 700 citations Larry M. Baddour, Walter R. Wilson et al. Circulation profile →
Management and Outcome of Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infections

2007 487 citations M. Rizwan Sohail, Daniel Z. Uslan et al. profile →
Challenges in Infective Endocarditis

2017 398 citations Larry M. Baddour, Gilbert Habib et al. profile →
Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis

2014 332 citations Mark Dayer, Bernard Prendergast et al. profile →
Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association

2016 302 citations Walter R. Wilson, Patrick T. O’Gara et al. Circulation profile →

Peers

Countries citing papers authored by Larry M. Baddour

Since Specialization

Citations

This map shows the geographic impact of Larry M. Baddour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry M. Baddour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry M. Baddour more than expected).

Fields of papers citing papers by Larry M. Baddour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry M. Baddour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry M. Baddour. The network helps show where Larry M. Baddour may publish in the future.

Co-authorship network of co-authors of Larry M. Baddour

This figure shows the co-authorship network connecting the top 25 collaborators of Larry M. Baddour. A scholar is included among the top collaborators of Larry M. Baddour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry M. Baddour. Larry M. Baddour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blood Culture Time to Positivity and Risk of Infective Endocarditis 2025 ·Clinical Infectious Diseases ·(unknown), Omar Abu Saleh, Supavit Chesdachai, Brian D. Lahr, Héctor I. Michelena, (unknown), Hector R. Villarraga, Daniel C. DeSimone, Larry M. Baddour	0
2	Infective endocarditis: it takes a team 2025 ·European Heart Journal ·Lawrence Lau, Larry M. Baddour, Núria Fernández-Hidalgo, Thomas D. Brothers, William Kong, Michael A. Borger, Xavier Duval, Christophe Tribouilloy, Jean‐François Obadia, Mehrdad Golian, Vicente Corrales‐Medina, François Auclair, Mikaël Mazighi, Kwan L. Chan, Bernard Prendergast, Gilbert Habib, Fraser D. Rubens, David Messika‐Zeitoun	5
3	Percutaneous Mechanical Aspiration in Infective Endocarditis: Applications, Technical Considerations, and Future Directions 2024 ·Journal of the Society for Cardiovascular Angiography & Interventions ·Abdallah El Sabbagh, Evin Yucel, David M. Zlotnick, John M. Moriarty, (unknown), Nadira Hamid, Yasir Akhtar, Larry M. Baddour, Patrick T. O’Gara, Christoph Starck, Sripal Bangalore, Sahil A. Parikh, Kenneth Rosenfield, Sanjum S. Sethi	4
4	Fostering Collaborative Teamwork—A Comprehensive Approach to Vascular Graft Infection Following Arterial Reconstructive Surgery 2024 ·Clinical Infectious Diseases ·Hussam Tabaja, Supavit Chesdachai, Aditya Shah, Ryan W. Stevens, Randall R. DeMartino, Young Erben, Walter R. Wilson, Larry M. Baddour, Daniel C. DeSimone	1
5	Percutaneous mechanical aspiration in patients with right‐sided infective endocarditis: An analysis of the national inpatient sample database—2016–2020 2024 ·Catheterization and Cardiovascular Interventions ·Sara F. Haddad, Brian D. Lahr, Abdallah El Sabbagh, Walter R. Wilson, Supavit Chesdachai, Daniel C. DeSimone, Larry M. Baddour	0
6	Epidemiology of infective endocarditis: novel aspects in the twenty-first century 2022 ·Expert Review of Cardiovascular Therapy ·(unknown), Khawaja M. Talha, Larry M. Baddour	7
7	Utility of Metagenomic Next-Generation Sequencing in Infective Endocarditis: A Systematic Review 2022 ·Antibiotics ·Sara F. Haddad, Daniel C. DeSimone, Supavit Chesdachai, Dana Gerberi, Larry M. Baddour	20
8	Infection Rate and Outcomes of Watchman Devices: Results from a Single-Center 14-Year Experience 2021 ·SHILAP Revista de lepidopterología ·Robert C. Ward, (unknown), (unknown), Shiva Ponamgi, Samuel J. Asirvatham, Larry M. Baddour, David R. Holmes, Daniel C. DeSimone, Christopher V. DeSimone	3
9	Bloodstream Infection Following Cardiac Valve Repair: A Population-Based Study 2021 ·Open Forum Infectious Diseases ·Jack McHugh, Khawaja M. Talha, Larry M. Baddour, Karen M. Fischer, Juan A. Crestanello, Arman Arghami, Daniel C. DeSimone	1
10	Why are we seeing an increasing incidence of infective endocarditis in the UK? 2020 ·British Journal of Hospital Medicine ·Mark Dayer, Bernard Prendergast, Martin H. Thornhill, Larry M. Baddour	0
11	Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection 2019 ·Infection ·(unknown), (unknown), Christopher M. Watson, P. Brandon Bookstaver, Joseph Kohn, William B. Owens, Larry M. Baddour, Majdi N. Al‐Hasan	40
12	Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes 2019 ·Pacing and Clinical Electrophysiology ·(unknown), Katherine Le, Larry M. Baddour, M. Rizwan Sohail, Holenarasipur R. Vikram, Marta Hernández‐Meneses, José M. Miró, Jordan M. Prutkin, Arnold J. Greenspon, Roger G. Carrillo, (unknown), Christoph Naber, (unknown), Chi‐Hong Tseng, Daniel Z. Uslan, James E. Peacock	7
13	Attempted salvage of infected cardiovascular implantable electronic devices: Are there clinical factors that predict success? 2018 ·Pacing and Clinical Electrophysiology ·James E. Peacock, Jeanette M. Stafford, Katherine Le, M. Rizwan Sohail, Larry M. Baddour, Jordan M. Prutkin, Stephan B. Danik, Holenarasipur R. Vikram, Marta Hernández‐Meneses, José M. Miró, (unknown), Christoph Naber, Roger G. Carrillo, Arnold J. Greenspon, Chi‐Hong Tseng, Daniel Z. Uslan	18
14	Hospital costs for patients with lower extremity cellulitis: a retrospective population-based study 2017 ·Hospital Practice ·Douglas W. Challener, Jasmine R Marcelin, Sue L. Visscher, Larry M. Baddour	10
15	Ebola Virus Disease in Guinea 2014 ·Journal watch ·Larry M. Baddour	19
16	Correction: The Association between Histamine 2 Receptor Antagonist Use and Clostridium difficile Infection: A Systematic Review and Meta-analysis 2013 ·PLoS ONE ·Imad M. Tleyjeh, Aref A. Bin Abdulhak, Muhammad Riaz, Musa A. Garbati, Mohamad Al‐Tannir, Faisal Alasmari, Mushabab Alghamdi, Abdur Rahman Khan, Patricia J. Erwin, Alex J. Sutton, Larry M. Baddour	4
17	Quality and Strength of Evidence of the Infectious Diseases Society of America Clinical Practice Guidelines 2010 ·Clinical Infectious Diseases ·Abdur Rahman Khan, Sobia Khan, Valerie Zimmerman, Larry M. Baddour, Imad M. Tleyjeh	77
18	Persistent West Nile Virus Infection 2010 ·Journal watch ·Larry M. Baddour	0
19	Direct Cardiovascular Implications of Emerging Infectious Diseases and Biological Terrorism Threats 2007 ·Circulation ·Larry M. Baddour, Zhi Zheng, Darwin R. Labarthe, (unknown)	1
20	Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia 2004 ·American Journal of Respiratory and Critical Care Medicine ·Larry M. Baddour, Victor L. Yu, Keith P. Klugman, Charles Feldman, Åke Örtqvist, Jordi Rello, Arthur J. Morris, Carlos M. Luna, David R. Snydman, Wen‐Chien Ko, Maria Bernadete Fernandes Chedid, David S.C. Hui, Antoine Andremont, Christine C. Chiou	301

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact